UroGen Pharma Analyst Price Targets

PRO

¿Por qué se mueve?:UroGen Pharma shares are trading lower after the company reported worse-tha...

Ganancias: Los beneficios de Q3 2026 se publicaron el mié nov 4th, antes de la apertura del mercado

Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 10:00 a. m., hace 1 día

Wall Street analyst price targets and consensus rating for UroGen Pharma (URGN).

Price Target Range — 13 Quarters

Analyst Consensus — 8 Analysts

7Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$42Upside to Avg. PT+59.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Guggenheim	Michael Schmidt	PT Cut	Buy	$58→$56
Oct 19, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$75
Aug 6, 2026	Guggenheim	Michael Schmitz	PT Raise	Buy	$42→$58
Aug 6, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$45→$75
Aug 5, 2026	TD Cowen	Tara Bancroft	PT Raise	Buy	$50→$60
Jul 21, 2026	Guggenheim	Brad Canino	PT Raise	Buy	$32→$42
Jul 16, 2026	Oppenheimer	Leland Gershell	PT Raise	Outperform→Outperformer	$40→$50
Jun 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$45
May 18, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$45
May 11, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$40→$45
May 7, 2026	Oppenheimer	Leland Gershell	PT Raise	Outperform	$34→$40
Mar 31, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
Mar 2, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
Jan 23, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
Jan 5, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
Oct 27, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$40
Oct 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$25
Oct 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$25
Aug 19, 2025	Piper Sandler	Kelsey Goodwin	Initiate	Overweight	$36
Aug 11, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$50→$40